Some people actually function on only 4 hours of #sleep a night. 😲 Their 'superhuman' ability is linked to unique #genes like DEC2 & ADRB1, making their sleep ultra-efficient. 🌙 🧬 "These genes may help control processes like orexin production, which promotes wakefulness at a cellular level." Full read: https://bit.ly/3ZPdvXr #SleepScience #Insight #GeneticResearch #BGIGeneTest
BGI Genomics
生物技术
BGI Genomics, based in China, is the world’s leading provider of genetic tests and sequencing services.
关于我们
BGI was founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI’s in-house research has contributed to the development of the field of Genomics in significant ways, as evidenced by a wealth of peer-reviewed publications in prestigious scientific journals. Today, BGI is actively participating in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a global network of collaborators. BGI Genomics is the world’s leading provider of genomic and proteomic services, now serving customers in more than 66 countries. We provide academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic and proteomic services and solutions across a broad range of applications spanning basic and translational research, drug discovery, agriculture and health care. To provide these services, we operate a large network of service Laboratories in China, Hong Kong, the US and Europe. Our customers benefit from the highest level of sequencing experience in the world to support their research and drug discovery projects. Our service laboratories operate under strict internationally recognized quality systems, such as those from CAP and ISO. More recently, BGI developed and launched its own DNBseq™ sequencing technology, based on DNA Nanoball sequencing technology that was invented in our Complete Genomics research facility in Silicon Valley, California. Scientists around the world now rely on DNBseq NGS services for the highest quality data at the lowest cost.
- 网站
-
https://www.bgi.com/global
BGI Genomics的外部链接
- 所属行业
- 生物技术
- 规模
- 5,001-10,000 人
- 类型
- 上市公司
- 创立
- 1999
- 领域
- Next Generation Sequencing、NGS、Analytical Services、Molecular testing、Bioinformatics、Whole Genome Sequencing、RNA Sequencing、Proteomics、Protein Characterization、Mass Spectrometry、Drug Discovery和Metagenomics
地点
BGI Genomics员工
动态
-
Empowering families worldwide, we’re proud to support the journey to parenthood with innovative #ReproductiveHealth services. 👶 🧬 From pre-conception #GeneticInsights to comprehensive maternal health and neonatal care, our cutting-edge solutions have ensured accurate, affordable #EarlyDetection of genetic conditions. Trusted globally, our advanced testing tools safeguard the health of future generations, enabling families to make confident, informed decisions for a brighter, healthier tomorrow. 🌍 #PrenatalScreening #FetalHealth #GenomicsInnovation #BGIGeneTest
-
🩸 Blood: A Living Diary of Health 🩸 Did you know that your blood doesn’t just reflect your current health—it holds the key to understanding future risks? 🌟 In the latest of our Chat!DNA Expert Interview, we spotlight Li Jia, whose work is revolutionizing early disease detection. 🧬 For the past nine years, Li Jia, a dedicated research scientist at BGI Genomics’ Institute of Intelligent Medical Research (IIMR), has been decoding the hidden bio-information in blood. His groundbreaking work is transforming how we detect and predict gestational diseases, tumor risks, and chronic conditions. 🎥 Read the article and watch his interview to learn more! https://bit.ly/49KZmyI #BGIGenomics #ChatDNA #ScientificResearch #YoungScientists #MedicalInnovation #Bioinformation #EarlyDiseaseDetection #OmicsRevolution
Unlocking Clues in Blood: Li Jia's Multi-Omics Revolution in Disease Prevention | Chat!DNA
bgi.com
-
New findings challenge decades-old beliefs about cancer growth.🧬 In new research, scientists reveal tumors grow uniformly throughout their mass, not just at the edges. This discovery uncovers a constant churn of cell activity across the tumor, creating more opportunities for mutations that drive cancer progression and therapy resistance. “We challenge the idea that a tumor is a ‘two-speed’ entity with rapidly dividing cells on the surface and slower activity in the core. Instead, we show they are uniformly growing masses, where every region is equally active and has the potential to harbor aggressive mutations.” 🗣️ Read more: https://bit.ly/49I6M63 #CancerResearch #CellActivity #Insight #BGIGeneTest
New Research Overturns Decades-Old Beliefs About How Cancer Grows and Spreads
https://scitechdaily.com
-
🦟 Mosquito-Borne Diseases Are Spreading – Here’s How We Fight Back 🌍 This year alone, #DengueFever has claimed over 10,000 lives worldwide. As rising temperatures expand mosquito breeding grounds, outbreaks are reaching regions once considered safe. The threat is clear, but so is the solution. BGI Genomics’ PMseq™, powered by metagenomic next-generation sequencing (mNGS). This technology is reshaping how we detect and respond to mosquito-borne diseases. Faster, more accurate, and far-reaching, PMseq™ identifies pathogens in record time, enabling life-saving treatments when every second counts. The battle against mosquito-borne diseases demands global action: ✅ Invest in advanced diagnostics like PMseq™ ✅ Strengthen vector control efforts ✅ Prioritize climate resilience The time to act is now—together, we can protect communities and save lives. 🌎 Read more: https://bit.ly/4gCAxr7 #PMseq #ClimateChange #InfectiousDiseases #BGIGeneTest
Act Before the Season: Warmer Weather Drives a Surge in Deadly Mosquito-Borne Diseases | BGI Insight
bgi.com
-
🌍 On December 13th, Maryam Nawaz Sharif, Chief Minister of Punjab, Pakistan, led a delegation to BGI Genomics to sign a groundbreaking Memorandum of Understanding (MoU). This partnership focuses on building medical testing platforms, enhancing disease prevention, and advancing #PrecisionMedicine services with the Government of Punjab in Pakistan. The MoU was signed by Ms. Marriyum Aurangzeb and Mao Zhixia. Chief Minister Maryam Nawaz Sharif and Chairman Wang Jian witnessed the signing ceremony. Aligned with the China-Pakistan Economic Corridor and the "Belt and Road" initiative, this partnership contributes to building a global community dedicated to #BetterHealthForAll. 🤝Together, we look forward to creating transformative solutions in healthcare and public health in #Pakistan. ⬇️ Follow us for more exciting #GlobalHealth updates! #HealthcareInnovation #StrategicPartnership #update #BeltandRoadInitiative #BGIGeneTest
Pakistani Delegation Strengthens Partnership with BGI Genomics in Precision Medicine
bgi.com
-
Technology transfer is more than just the exchange of innovations—it’s about delivering advanced health solutions that empower communities and transform healthcare systems. We’re truly honored to have our efforts recognized by our valued partners: ✨ Zentya in Slovakia and NIMGenetics in Spain share their experiences on how BGI Genomics’ initiatives are advancing genetic testing and improving patient outcomes. 🗨️ “BGI Genomics has supported us primarily in two pillars that we consider the most important when you are a partner with someone: training and technical service," said our partner NIMGenetics in the interview video. With over 100 technology transfer projects completed in 36 countries, we’ve collaborated with partners across #Uruguay, #Thailand, #Kazakhstan, #UAE, #Rwanda, #Vietnam, #India, #Spain, #Mexico, #Indonesia, #Malaysia, and beyond. Together, we’ve successfully implemented solutions like NIPT, cWES, carrier screening, CRC detection, and hereditary cancer testing—delivering affordable reproductive health and cancer screening services to millions globally. Discover how we’re shaping the future of #PrecisionMedicine and making a lasting impact. 💙 #HealthcareInnovation #TechnologyTransfer #BGIInsight #BGIGeneTest
-
🌟 On December 6th, we were honored to host distinguished visitors from the China-ASEAN cervical and breast cancer prevention and control talent training class. 🌏 Representatives from 12 countries, including Thailand, Malaysia, Indonesia, Brunei, Vietnam, the Philippines, Cambodia, Laos and more, joined us for this meaningful exchange. The visit was warmly welcomed by Li Ning, Deputy General Manager of BGI Genomics, and Jeremy (Sujie) cao, General Manager of BGI Genomics Southeast Asia. At BGI Genomics, we are dedicated to advancing #PublicHealth in ASEAN countries by leveraging China’s proven healthcare models. Our mission is to make #Genetic technology accessible and impactful for all, ensuring a healthier future worldwide. 💙 ⬇️Follow us for more global health updates. #OmicsForAll #ASEANHealth #PrecisionMedicine #BGIGeneTest
-
Cancer isn’t a uniform mass—it’s a complex ecosystem of diverse cells. Advances in #SpatialOmics now allow researchers to map molecular processes within tumors, uncovering hidden vulnerabilities and guiding more precise treatments. “We’re not just talking about tumour heterogeneity any more — we can see it. We can see pockets of drug resistance, sensitivity and different biology directly on the tissue.” Read more: https://lnkd.in/ehP5jqh2 #CancerResearch #PrecisionMedicine #BGIGeneTest
Why tumour geography matters — and how to map it
nature.com
-
🧬 Scientists have developed T cells with a brain-specific molecular GPS to precisely target glioblastoma, a highly challenging brain cancer. These smart #ImmuneCells eliminate tumors while sparing healthy tissue, marking a promising step forward for treating #cancer and other hard-to-treat CNS diseases. Read more: https://lnkd.in/djEG62Cj #CancerResearch #Immunotherapy #Insight #BGIGeneTest
Programming tissue-sensing T cells that deliver therapies to the brain
science.org